160 related articles for article (PubMed ID: 21605937)
1. Importance of monitoring renal function in patients with cancer.
Aapro M; Launay-Vacher V
Cancer Treat Rev; 2012 May; 38(3):235-40. PubMed ID: 21605937
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study.
Launay-Vacher V; Oudard S; Janus N; Gligorov J; Pourrat X; Rixe O; Morere JF; Beuzeboc P; Deray G;
Cancer; 2007 Sep; 110(6):1376-84. PubMed ID: 17634949
[TBL] [Abstract][Full Text] [Related]
3. Drug management of prostate cancer: prevalence and consequences of renal insufficiency.
Launay-Vacher V; Ayllon J; Janus N; Spano JP; Ray-Coquard I; Gligorov J; Pourrat X; Morere JF; Beuzeboc P; Deray G; Oudard S;
Clin Genitourin Cancer; 2009 Oct; 7(3):E83-9. PubMed ID: 19815487
[TBL] [Abstract][Full Text] [Related]
4. Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patients.
Launay-Vacher V; Izzedine H; Rey JB; Rixe O; Chapalain S; Nourdine S; Paci A; Bourget P; Deray G
Med Sci Monit; 2004 May; 10(5):CR209-12. PubMed ID: 15114271
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials.
Miller PD; Roux C; Boonen S; Barton IP; Dunlap LE; Burgio DE
J Bone Miner Res; 2005 Dec; 20(12):2105-15. PubMed ID: 16294264
[TBL] [Abstract][Full Text] [Related]
6. Occult renal impairment is common in patients with peripheral vascular disease and normal serum creatinine.
Rashid ST; Salman M; Agarwal S; Hamilton G
Eur J Vasc Endovasc Surg; 2006 Sep; 32(3):294-9. PubMed ID: 16716614
[TBL] [Abstract][Full Text] [Related]
7. [Incidence, risk factors and prevention of cisplatin-induced nephrotoxicity in patients with lung cancer].
Losonczy G; Máthé C; Müller V; Szondy K; Moldvay J
Magy Onkol; 2010 Dec; 54(4):289-96. PubMed ID: 21163759
[TBL] [Abstract][Full Text] [Related]
8. Renal disease in patients with cancer.
Finkel KW; Foringer JR
Nat Clin Pract Nephrol; 2007 Dec; 3(12):669-78. PubMed ID: 18033226
[TBL] [Abstract][Full Text] [Related]
9. Comparison of estimated glomerular filtration rate with estimated creatinine clearance in the dosing of drugs requiring adjustments in elderly patients with declining renal function.
Spruill WJ; Wade WE; Cobb HH
Am J Geriatr Pharmacother; 2008 Aug; 6(3):153-60. PubMed ID: 18775390
[TBL] [Abstract][Full Text] [Related]
10. Assessment of renal function in recently admitted critically ill patients with normal serum creatinine.
Hoste EA; Damen J; Vanholder RC; Lameire NH; Delanghe JR; Van den Hauwe K; Colardyn FA
Nephrol Dial Transplant; 2005 Apr; 20(4):747-53. PubMed ID: 15701668
[TBL] [Abstract][Full Text] [Related]
11. Influence of co-morbidity on renal function assessment by Cockcroft-Gault calculation in lung cancer and mesothelioma patients receiving platinum-based chemotherapy.
Hubner RA; Goldstein R; Mitchell S; Jones A; Ashley S; O'Brien ME; Popat S
Lung Cancer; 2011 Sep; 73(3):356-60. PubMed ID: 21334759
[TBL] [Abstract][Full Text] [Related]
12. Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study.
Karie S; Gandjbakhch F; Janus N; Launay-Vacher V; Rozenberg S; Mai Ba CU; Bourgeois P; Deray G
Rheumatology (Oxford); 2008 Mar; 47(3):350-4. PubMed ID: 18238787
[TBL] [Abstract][Full Text] [Related]
13. Kidney function estimating equations in patients with chronic kidney disease.
Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
Int J Clin Pract; 2011 Apr; 65(4):458-64. PubMed ID: 21401834
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United States.
Arellano J; Hernandez RK; Wade SW; Chen K; Pirolli M; Quach D; Quigley J; Liede A; Shahinian VB
Cancer Med; 2015 May; 4(5):713-20. PubMed ID: 25663171
[TBL] [Abstract][Full Text] [Related]
15. How to assess renal function in the geriatric population.
Aucella F; Guida CC; Lauriola V; Vergura M
J Nephrol; 2010; 23 Suppl 15():S46-54. PubMed ID: 20872371
[TBL] [Abstract][Full Text] [Related]
16. [Nephrotoxicity induced by chemotherapy].
Di Vito R; Sirolli V; Amoroso L; Bonomini M
G Ital Nefrol; 2011; 28(3):296-304. PubMed ID: 21626498
[TBL] [Abstract][Full Text] [Related]
17. Transplantation: impact of pretransplant renal insufficiency.
Bahirwani R; Campbell MS; Siropaides T; Markmann J; Olthoff K; Shaked A; Bloom RD; Reddy KR
Liver Transpl; 2008 May; 14(5):665-71. PubMed ID: 18433034
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.
Hermsen ED; Maiefski M; Florescu MC; Qiu F; Rupp ME
Pharmacotherapy; 2009 Jun; 29(6):649-55. PubMed ID: 19476418
[TBL] [Abstract][Full Text] [Related]
19. Flat dosing of carboplatin is justified in adult patients with normal renal function.
Ekhart C; de Jonge ME; Huitema AD; Schellens JH; Rodenhuis S; Beijnen JH
Clin Cancer Res; 2006 Nov; 12(21):6502-8. PubMed ID: 17085665
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function.
Welink J; Boven E; Vermorken JB; Gall HE; van der Vijgh WJ
Clin Cancer Res; 1999 Sep; 5(9):2349-58. PubMed ID: 10499604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
